de Graaff LCG - Search Results

1

Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.

Damen L, Grootjen LN, Donze SH, Juriaans AF, de Graaff LCG, van der Velden JAEM, Hokken-Koelega ACS. Damen L, et al. Among authors: de graaff lcg. Clin Endocrinol (Oxf). 2020 Oct;93(4):439-448. doi: 10.1111/cen.14274. Epub 2020 Jul 22. Clin Endocrinol (Oxf). 2020. PMID: 32609902 Clinical Trial.

2

Body proportions before and during growth hormone therapy in children with chronic renal failure.

de Graaff LC, Mulder PG, Hokken-Koelega AC. de Graaff LC, et al. Pediatr Nephrol. 2003 Jul;18(7):679-84. doi: 10.1007/s00467-003-1090-8. Epub 2003 May 7. Pediatr Nephrol. 2003. PMID: 12734746 Clinical Trial.

3

GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age.

de Graaff LC, Meyer S, Els C, Hokken-Koelega AC. de Graaff LC, et al. Clin Endocrinol (Oxf). 2008 Jun;68(6):930-4. doi: 10.1111/j.1365-2265.2007.03140.x. Epub 2007 Nov 19. Clin Endocrinol (Oxf). 2008. PMID: 18031312

4

Facial and pituitary morphology are related in Dutch patients with GH deficiency.

de Graaff LC, Baan J, Govaerts LC, Hokken-Koelega AC. de Graaff LC, et al. Clin Endocrinol (Oxf). 2008 Jul;69(1):112-6. doi: 10.1111/j.1365-2265.2007.03167.x. Epub 2008 Jul 1. Clin Endocrinol (Oxf). 2008. PMID: 18182094

5

Genetic screening of a Dutch population with isolated GH deficiency (IGHD).

de Graaff LC, Argente J, Veenma DC, Herrebout MA, Friesema EC, Uitterlinden AG, Drent ML, Campos-Barros A, Hokken-Koelega AC. de Graaff LC, et al. Clin Endocrinol (Oxf). 2009 May;70(5):742-50. doi: 10.1111/j.1365-2265.2008.03414.x. Epub 2008 Sep 10. Clin Endocrinol (Oxf). 2009. PMID: 18785993

6

Antipituitary antibodies in dutch patients with idiopathic hypopituitarism.

de Graaff LC, De Bellis A, Bellastella A, Hokken-Koelega AC. de Graaff LC, et al. Horm Res. 2009 Jan;71(1):22-7. doi: 10.1159/000173738. Epub 2008 Nov 27. Horm Res. 2009. PMID: 19039233

7

Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls.

de Graaff LC, Argente J, van Meurs JB, Uitterlinden AG, Hokken-Koelega AC. de Graaff LC, et al. Horm Res Paediatr. 2010;73(1):25-34. doi: 10.1159/000271913. Epub 2010 Jan 15. Horm Res Paediatr. 2010. PMID: 20190537

8

PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency.

de Graaff LC, Argente J, Veenma DC, Drent ML, Uitterlinden AG, Hokken-Koelega AC. de Graaff LC, et al. Horm Res Paediatr. 2010;73(5):363-71. doi: 10.1159/000308169. Epub 2010 Apr 14. Horm Res Paediatr. 2010. PMID: 20389107

9

Isolated GH deficiency: mutation screening and copy number analysis of HMGA2 and CDK6 genes.

Gorbenko del Blanco D, de Graaff LC, Posthouwer D, Visser TJ, Hokken-Koelega AC. Gorbenko del Blanco D, et al. Eur J Endocrinol. 2011 Oct;165(4):537-44. doi: 10.1530/EJE-11-0478. Epub 2011 Jul 29. Eur J Endocrinol. 2011. PMID: 21803798

10

Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.

Gorbenko del Blanco D, de Graaff LC, Visser TJ, Hokken-Koelega AC. Gorbenko del Blanco D, et al. Clin Endocrinol (Oxf). 2012 May;76(5):706-12. doi: 10.1111/j.1365-2265.2011.04304.x. Clin Endocrinol (Oxf). 2012. PMID: 22117696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters